The Association of Medical Specialists (AMS) has expressed deep concerns following the shocking revelations in a recent press release issued by the National Medicines Regulatory Authority over the adverse drug reactions to a brand of intravenous immunoglobulin (IVIG) distributed to state hospitals.
